Accueil>>Signaling Pathways>> Others>> Gutathione S-transferase>>GSTO-IN-2

GSTO-IN-2

Catalog No.GC33342

GSTO-IN-2 est un inhibiteur de la glutathion S-transférase avec des IC50 de 3,6, 16,3 et 1,4 μM pour GSTA2, GSTM1 et GSTP1-1.

Products are for research use only. Not for human use. We do not sell to patients.

GSTO-IN-2 Chemical Structure

Cas No.: 1202710-57-3

Taille Prix Stock Qté
10mM (in 1mL DMSO)
690,00 $US
En stock
5mg
506,00 $US
En stock
10mg
782,00 $US
En stock
25mg
1 609,00 $US
En stock
50mg
2 528,00 $US
En stock
100mg
3 631,00 $US
En stock

Tel:(909) 407-4943 Email: sales@glpbio.com

Avis des clients

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

GSTO-IN-2 is a glutathione S-transferase inhibitor with IC50s of 3.6, 16.3, and 1.4 μM for GSTA2, GSTM1, and GSTP1-1.

GSTO-IN-2 is compound 3 in the reference. GSTO-IN-2 shows synergetic effect with chemotherapy drugs against two breast cancer cell lines through the inactivation of GST isozymes. The maximal enhancement of cisplatin-induced inhibition of cell viability is observed at 50 μM GSTO-IN-2, up to 640% against MCF-7 and up to 270% against MDA-MB-231. Viability inhibition of thiotepa is enhanced by GSTO-IN-2 (25 and 50 μM), up to 170-320% against MCF-7 and up to 180-270% against MDA-MB-231.[1].

[1]. Chang KH, et al. Lithocholic acid analogues, new and potent alpha-2,3-sialyltransferase inhibitors. Chem Commun (Camb). 2006 Feb 14;(6):629-31.

Avis

Review for GSTO-IN-2

Average Rating: 5 ★★★★★ (Based on Reviews and 20 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for GSTO-IN-2

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.